Phase Ib/IIa study of AZD4573 and acalabrutinib in patients with R/R DLBCL
Alexey Danilov • 15 Jun 2023
Preliminary results examining use of AZD4573 in R/R hematological malignancies
Arnon Kater • 11 Dec 2022
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.